Meili Duan

机构：Jiangxi University of Traditional Chinese Medicine, Capital Medical University, Beijing Friendship Hospital · ORCID：0000-0001-5947-4938

发表论文 72 篇 · 总被引 1208 次 · h-index 20

代表论文

• Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis (2023 · JAMA Internal Medicine · 被引 101)
• Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial (2023 · Intensive Care Medicine · 被引 65)
• The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial (2025 · BMJ · 被引 24)
• Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China (2022 · Critical Care · 被引 21)
• Prognostic evaluation of quick sequential organ failure assessment score in ICU patients with sepsis across different income settings (2024 · Critical Care · 被引 17)
• COMPARISON AMONG PRESEPSIN, PROCALCITONIN, AND C-REACTIVE PROTEIN IN PREDICTING BLOOD CULTURE POSITIVITY AND PATHOGEN IN SEPSIS PATIENTS (2023 · Shock · 被引 14)